Cancer Screening in Inflammatory Bowel Disease : A Guide to Risk Management and Techniques / / edited by Joseph D. Feuerstein, Adam S. Cheifetz |
Edizione | [1st ed. 2019.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 |
Descrizione fisica | 1 online resource (XI, 174 p. 14 illus. in color.) |
Disciplina |
616.33
616.344 |
Soggetto topico |
Gastroenterology
Rectum—Surgery Oncology Gastroenterology Colorectal Surgery Oncology |
ISBN | 3-030-15301-0 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Epidemiology and Risk Factors for Colorectal Cancer in Inflammatory Bowel Diseases -- Screening for Colon Cancer in Inflammatory Bowel Disease -- Skin Cancer Risk and Screening in Patients with Inflammatory Bowel Disease -- Female Specific Cancern Risks and Screening in Inflammatory Bowel Disease -- Lymphoma Risk and Screening in Inflammatory Bowel Disease -- Pouch Neoplasia following IPAA in Patients with Underlying Inflammatory Bowel Diseases -- Other Cancers: Small Bowel Cancers, Cholangiocarcinoma, Urinary Tract, and Anal Cancer Risk and Screening in Inflammatory Bowel Disease -- Cancer Risks and Screening with Current and Emerging Drug Therapies in Inflammatory Bowel Diseases -- Preventing Colorectal Cancer in Patients with Inflammatory Bowel Diseases: Chemopreventive and Surgical Approaches -- Cancer Risk and Screening in Pediatric Patients -- Colorectal Cancer Risk and Screening in Geriatric Patients -- Use of Biologic Drugs Following an Initial Diagnosis of Malignancy. |
Record Nr. | UNINA-9910337509503321 |
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Treatment of Inflammatory Bowel Disease with Biologics / / edited by Adam S. Cheifetz, Joseph D. Feuerstein |
Edizione | [1st ed. 2018.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018 |
Descrizione fisica | 1 online resource (XI, 335 p. 22 illus., 19 illus. in color.) |
Disciplina | 616.33 |
Soggetto topico |
Gastroenterology
Gastroenterology |
ISBN | 3-319-60276-4 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Mechanism of Action and Pharmacokinetics of Biologics -- Anti-tumor Necrosis Factor Agents in Ulcerative Colitis -- Anti-tumor Necrosis Factor Agents in Crohn’s Disease -- Anti-TNF Therapy for Treatment of Extraintestinal Manifestations of Inflammatory Bowel Disease -- Use of Biologics in the Postoperative Management of Crohn’s Disease -- Biologics in Pregnancy and Breastfeeding -- Concomitant Use of Immunosuppressive Therapy with Tumor Necrosis Factor (TNF) Antagonists in Inflammatory Bowel Disease -- Therapeutic Drug Monitoring of Biologic Agents -- Use of Biologics in Crohn’s Disease and Ulcerative Colitis Prior to Surgery and Perioperative Risks -- Cessation of Biologics – Can it be Done? -- Biologic Therapy in Pediatric Inflammatory Bowel Disease -- Infectious Complications of Biologics -- Tumor Necrosis Factor-Alpha Inhibitors and Risks of Malignancy -- Non-infectious and Non-malignant Complications of Biologics -- Biosimilars in Inflammatory Bowel Disease 2017: State of the Science, State of the Art, State of the Finances -- Anti-Integrin Agents in IBD: Efficacy and Risk of Complications -- Novel Agents in Inflammatory Bowel Disease -- Quality, Safety, and Practical Considerations of Using Biologic Therapies. . |
Record Nr. | UNINA-9910300312303321 |
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|